MAPK8 and metabolic dysfunction-associated steatohepatitis: Mechanistically, NSD2 directly governed the transcriptional activation of Ern1 through H3K36me2, thus activating the ERN1–JNK axis to exacerbate intestinal barrier impairment and subsequently promote NASH progression.